← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $798K of BioMarin Pharmaceutical Inc.

Sold$797,520
$88.61Price
9,000Shares
−2%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, May 1. Filed Tue, May 5, 7:22 PM ET, after the close. Not investment advice.